Motus GI Holdings

MOTS · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0002

About MOTS

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.

Employees
15
Headquarters
FORT LAUDERDALE, Florida
Listed
Feb 14, 2018
Sector
Health Care
Industry
Health Care Equipment & Supplies

MOTS key statistics

Market cap
1.28K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
893
Volume
2.51K
Open price
$0.0002
High today
$0.0002
Low today
$0.0002
52 Week high
$0.10
52 Week low
$0.00

Motus GI Holdings (MOTS) at a glance

Motus GI Holdings (MOTS) last traded at $0.0002, with a market cap of 1.28K and a price-to-earnings ratio of 0.00.

Volume so far is 2.51K shares, above the average of 893 shares a day.

Over the past year Motus GI Holdings has ranged from $0.00 to $0.10, and now sits 0% of the way up that range.

Motus GI Holdings met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q4 FY23 it reported -$4.48 per share against an estimate of -$4.27.

MOTS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 23.3% on average.

  1. Q1 FY22: reported -$27.00 per share against an estimate of -$32.44
  2. Q2 FY22: reported -$27.90 per share against an estimate of -$30.72
  3. Q3 FY22: reported -$25.35 per share against an estimate of -$28.79
  4. Q4 FY22: reported -$11.85 per share against an estimate of -$17.98
  5. Q1 FY23: reported -$13.80 per share against an estimate of -$14.61
  6. Q2 FY23: reported -$6.00 per share against an estimate of -$9.28
  7. Q3 FY23: reported -$4.28 per share against an estimate of -$8.64
  8. Q4 FY23: reported -$4.48 per share against an estimate of -$4.27

Similar companies

Companies in the same industry as Motus GI Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.